|Conditional recommendation based on low-quality evidence; may consider an OSM if the patient does not have severe PsA,โก does not have severe psoriasis,ยง prefers oral therapy, has concern over starting a biologic as the first therapy, or has contraindications to TNFi biologics, including congestive heart failure, previous serious infections, recurrent infections, or demyelinating disease.| |
|2. Treat with a TNFi biologic over an IL-17i biologic (PICO 14)|Very low|